PET and SPECT in IMRT: Future prospects

Image-Guided IMRT

Volumn , Issue , 2006, Pages 171-176

  Van De Wiele, Christophe ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746847660     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/3-540-30356-1_13     Document Type: Chapter

References (48)

1. Eberl S, Zimmerman RE (1998) Nuclear medicine imaging instrumentation. In: Muray IPC, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment. Churchill Livingstone, Edinburgh, pp 1559-1569
2. Bailey DL, Parker JA (1998) Single photon emission computed tomography. In: Muray IPC, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment. Churchill Livingstone, Edinburgh, pp 1589-1601
3. Meikle SR, DahlbomM(1998) Positron emission tomography. In: Muray IPC, Ell PJ (eds) Nuclear medicine in clinical diagnosis and treatment. Churchill Livingstone, Edinburgh, pp 1603-1616
4. Boyd RE, Silvester DJ (1998) Radioisotope production. In:Muray IPC, Ell PJ (eds)Nuclear medicine in clinical diagnosis and treatment. Churchill Livingstone, Edinburgh, pp 1617-1624
5. Jones T (1996) The imaging science of positron emission tomography. Eur J Nucl Med 23:807-813
6. Som P, Atkins HL, Bandoypadhyay D et al. (1980) A fluorinated glucose analogue, 2-fluoro-2-deoxy-D-glucose (F-18): non-toxic tracer for rapid tumour detection. J Nucl Med 21:670-675
7. Warburg O (1956) On the origin of cancer cells. Science 123:309-314
8. Flier JS, Mueckler MM, Usher P, Lodish HF (1987) Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235:1492-1495
9. WeberWA, Avril N, SchwaigerM(1999) Relevance of positron emission tomography (PET) in oncology. Stralenther Onkol 175:356-373
10. Dahlbom M, Hoffman E, Hoh CK, Schiepers C, Rosenqvist G, Hawkins RA, Phelps ME (1992)Whole- body positron emission tomography: part I.Methods and performance characteristics. J Nucl Med 33:1191-1199
11. Strauss LG (1996) Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 23:1409-1415
12. Mutic S, Malyapa RS, Grigsby PW et al. (2003) PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes-a dose-escalation treatment planning study. Int J Radiat Oncol Biol Phys 55:28-35
13. Grills IS, Yan D,Martinez AA, Vicini FA, Wong JW, Kestin LL (2003) Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, andelectivenodal irradiation. Int JRadiat Oncol Biol Phys 57:875-890
14. Scarfone C, Lavely WC, Cmelak AJ, Delbeke D, Martin WH, Billheimer D, HallahanDE(2004)Prospective feasibility trialof radiotherapy target definition for head and neck cancer using 3-dimensional PET and CT imaging. J Nucl Med 45:543-552
15. Mendelsohn ML (1960) The growth fraction: a new concept applied to tumours. Science 132:1496-1503
16. Slingerland JM, Tannock IF (1987) Cell proliferation and cell death. In: Tannock IF, Hill RP (eds) The basic science of oncology, 3rd edn. McGraw- Hill, New York, pp 134-165
17. Van deWiele C, De Bondt P, Peeters M, Vermeersch H, Dierckx RA (2002) Radiolabelled thymidines and deoxyuridines for measuring cellular proliferation in tumours - an update. Nucl Med Commun 23:925-931
18. Souba WW, Pacitti AJ (1992) How amino acids get into cells: mechanisms,models, menus and mediators. J Parenter Enteral Nutr 16:569-578
19. Christensen HN (1990) Role of amino acid transport and countertransport in nutrition and metabolism. Phys Rev 70:43-77
20. Oxender DL, Christensen HN (1963) Distinct mediating systems for the transport of neutral amino acids by the Ehrlich cell. J Biol Chem 238:3686-3699
21. Shotwell A, Jayme DW, Killberg M et al. (1981) Neutral amino acid transport systems in Chinese hamster ovary cells. J Biol Chem 256:5422-5427
22. Isselbacher KJ (1972) Sugar and amino acid transport by cells in culture: differences between normal and malignant cells. N Engl J Med 286:929-933
23. Busch H, Davis JR, Honig GR et al. (1959) The uptake of a variety of amino acids into nuclear proteins of tumors and other tissues. Cancer Res 19:1030-1039
24. Argiles JM, Costelli P, Carbo N et al. (1999) Tumour growth and nitrogen metabolism in the host. Int J Oncol 14:479-486
25. Souba WW (1993) Glutamine and cancer. Ann Surg 218:715-728
26. Kubato K, Yamada S, Kubota R et al. (1992) Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33:1972-1980
27. Kubota R, Kubota K, Yamada S et al. (1995)Methionine uptake by tumor tissue: a microautoradiographic comparison with FDG. J Nucl Med 36:484-492
28. Kubota K, Matsuzawa T, Fujiwara T et al. (1989) Differential diagnosisofAH109Atumor and inflammation by radioscintigraphy with L-[methyl-11C]-methionine. Jpn J Cancer Res 80:778-782
29. Fyles AW, Milosevic M, Wong R et al. (1998) Oxygenation predicts radiationresponse and survival inpatientswith cervix cancer. Radiother Oncol 48:149-156
30. Hockel M, Schlenger K, Hockel S, Vaupel P (1999) Association between tumor hypoxia and malignant progression: the clinical evidence in cancer of the uterine cervix. In: Vaupel P, Kelleher DK (eds) Tumour hypoxia. Wissenschaftliche Verlagsgesellschaft mbH., Stuttgart, pp 65-74
31. NordsmarkM, OvergaardM, Overgaard J (1996) Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41:31-39
32. Koh WJ, Rasey JS, Evans ML et al. (1992) Imaging of hypoxia in human tumors with (F-18)fluoromisonidazole. Int J Radiat Oncol Biol Phys 22(1):199-212
33. Koh WJ, Bergman KS, Rasey JS et al. (1995) Evaluation of oxygenation status during fractionated radiotherapy in human non-small cell lung cancers using (F-18)fluoromisonidazole positron emission tomography. Int J Radiat Oncol Biol Phys 33(2):391-398
34. Rasey JS, Koh WJ, EvansML et al. (1996) Quantifying regional hypoxia in human tumorswith positron emission tomography of (F-18)fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys 36(2):417-428
35. Parliament MB, Chapman JD, Urtasun RC et al. (1992) Non-invasive assessment of human tumour hypoxiawith 123Iiodoazomycin arabinoside: preliminary report of a clinical study. Br J Cancer 65:90-95
36. Urtasun RC, Parliament MB, McEwan AJ et al. (1996) Measurement of hypoxia in human tumors by non-invasive spect imaging of iodoazomycin arabinoside. Br J Cancer 74:S209-S212
37. Groshar D,McEwan AJB, Parliament MB et al. (1993) Imaging tumor hypoxia and tumor perfusion. J Nucl Med 34:885-888
38. Cook GJR, Houston S, Barrington SF, Fogelman I (1998) Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with Fluorine-18-FDG. J Nucl Med 103:39-99
39. Van de Wiele C, Versijpt J, Dierckx RA, Moerman M, LemmerlingM, D'AsselerY,VermeerschH(2001)Technetium-99m-labelled HL91 versus CT and biopsy for the visualisation of tumour recurrence of squamous head and neck carcinoma. Nucl Med Commun 22:269-275
40. Takahashi N, Fujibayashi Y, Yonekura Y et al. (2000) Evaluation ofCu-62 labeled diacetyl-bis(N-4-methoylthiosemicarbazone) as ahypoxic tissue tracer inpatientswithlung cancer.AnnNucl Med 14(5):323-328
41. Siim BG, Laux WT, Rutland MD, Palmer BN, Wilson WR (2000) Scintigraphic imaging of the hypoxia marker (99m)technetium-labelled 2, 2-(1,4-diaminobutane)- bis(2-methyl-3-butanone)dioxime (Tc-99m-labeled HL-91; Prognox): Noninvasivedetectionoftumor response to the antivascular agent 5.6-dimethylxanthenone-4-acetic acid. Cancer Res 60(16):4582-4588
42. Chao KS, Bosch WR, Mutic S et al. (2001) A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49(4):1171-1182
43. van Engeland M, Nieland LJW, Ramaekers FCS et al. (1998) Annexin-V-affinity assay: a review on an apoptosis detection systembased on phosphatidylserine exposure. Cytometry 31:1-9
44. Narula J, Acio ER, Narula N et al. (2001) Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nature Med 7:1347-1352
45. Hofstra L, Liem IH, Dumont EA et al. (2000) Visualisation of cell death in vivo in patients with acutemyocardial infarction. Lancet 356:209-212
46. Blankenberg FG, Vriens PW, Tait JF et al. (1998) Non-invasive detection and quantification of acute heart transplant rejection using 99mTc radio-labeled annexin V (Abstr). Radiology 1337
47. Narula J, Acia ER, Narula N et al. (2000) Phase-I Tc99m-Annexin-V imaging study in heart transplant rejection: can noninvasive detection of apoptosis in cardiac allografts obviate the need for endomyocardial biopsy (Abstr). Circulation 102:3714
48. Harari PM,Huang SM(2004)Combining EGFR inhibitorswith radiation or chemotherapy: will preclinical studies predict clinical results? Int J Radiat Oncol Biol Phys 58:976-983